咽峡炎链球菌与星座链球菌粪便特征用于胃癌无创筛查与早期预警
该观察性研究纳入中国10家医院1043例患者,通过16S rRNA基因分析发现胃癌与慢性胃炎间差异微生物,并用定量PCR验证咽峡炎链球菌(Sa)和星座链球菌(Sc)粪便标志物。Sa∪Sc在早期胃癌检测中灵敏度91.1%,优于晚期胃癌的81.4%,并在验证队列中证实。
要点
- 粪便Sa和Sc在胃癌上皮内瘤变、早期及晚期胃癌中显著富集。
- Sa∪Sc检测早期胃癌灵敏度91.1%,优于晚期胃癌的81.4%。
- Sa∪Sc诊断晚期胃癌灵敏度优于Sa∪CEA和Sc∪CEA。
核心结论
- 粪便Sa和Sc是胃癌早期预警的无创、准确且敏感的标志物。
研究设计与样本
- 观察性研究,纳入中国10家医院1043例患者,发现队列行16S rRNA基因分析,训练队列行定量PCR,验证队列验证诊断效能。
主要发现
- 胃癌组织(P<.05)和粪便(P<.0001)中Sa和Sc显著富集,见于上皮内瘤变、早期和晚期胃癌患者。
- 检测早期胃癌灵敏度:Sa 75.6% vs 晚期72.1%(P<.05);Sc 84.4% vs 64.0%(P<.001);Sa∪Sc 91.1% vs 81.4%(P<.01)。
- 对应特异性:Sa 84.0% vs 83.9%;Sc 70.4% vs 82.3%;Sa∪Sc 64.0% vs 73.4%。
- 鉴别晚期胃癌灵敏度:Sa∪Sc 81.4% vs Sa∪CEA 74.2%(P<.01),Sa∪Sc 81.4% vs Sc∪CEA 72.3%(P<.01);特异性均为73.4% vs 81.0%。
- Sa∪Sc对早期和晚期胃癌的诊断性能在验证队列中得到验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Most patients with gastric cancer (GCa) are diagnosed at an advanced stage. We aimed to investigate novel fecal signatures for clinical application in early diagnosis of GCa. METHODS: This was an observational study that included 1043 patients from 10 hospitals in China. In the discovery cohort, 16S ribosomal RNA gene analysis was performed in paired samples (tissues and feces) from patients with GCa and chronic gastritis (ChG) to determine differential abundant microbes. Their relative abundances were detected using quantitative real-time polymerase chain reaction to test them as bacterial candidates in the training cohort. Their diagnostic efficacy was validated in the validation cohort. RESULTS: Significant enrichments of Streptococcus anginosus (Sa) and Streptococcus constellatus (Sc) in GCa tumor tissues (P < .05) and feces (P < .0001) were observed in patients with intraepithelial neoplasia, early and advanced GCa. Either the signature parallel test Sa∪Sc or single signature Sa/Sc demonstrated superior sensitivity (Sa: 75.6% vs 72.1%, P < .05; Sc: 84.4% vs 64.0%, P < .001; and Sa∪Sc: 91.1% vs 81.4%, P < .01) in detecting early GCa compared with advanced GCa (specificity: Sa: 84.0% vs 83.9%, Sc: 70.4% vs 82.3%, and Sa∪Sc: 64.0% vs 73.4%). Fecal signature Sa∪Sc outperformed Sa∪CEA/Sc∪CEA in the discrimination of advanced GCa (sensitivity: 81.4% vs 74.2% and 81.4% vs 72.3%, P < .01; specificity: 73.4% vs 81.0 % and 73.4% vs 81.0%). The performance of Sa∪Sc in the diagnosis of both early and advanced GCa was verified in the validation cohort. CONCLUSION: Fecal Sa and Sc are noninvasive, accurate, and sensitive signatures for early warning in GCa. (ClinicalTrials.gov, Number: NCT04638959).
引用
- Zhou CB, Pan SY, Jin P, et al. Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer. Gastroenterology. 2022. PMID: 35167866. doi:10.1053/j.gastro.2022.02.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。